BioSpace News Archive

Genetown

Insulet Raises Awareness for National Diabetes Awareness Month

Highlights Include Beyond Type Run Team NYC Marathon Sponsorship, NASDAQ Closing Bell Ceremony and Global Fundraising Events

November 5, 2018
·
5 min read
Policy

Vizient, Inc. Disappointed as CMS Finalizes 340B & “Site-Neutral” Policies in Final OPPS Rule

Vizient, Inc. is disappointed that the Centers for Medicare and Medicaid Services (CMS) opted to finalize site-neutral payment reductions and the expansion of payment cuts related to the 340B Drug Pricing Program in the final 2019 Outpatient Prospective Payment System (OPPS) rule.

November 5, 2018
·
2 min read
BioCapital

Urology Ultrasound Community Launched

The American Institute of Ultrasound in Medicine (AIUM) just launched its newest community for medical professionals practicing Urologic Ultrasound

November 5, 2018
·
1 min read
Pharm Country

Initial results from EMPRISE real-world evidence study show Jardiance® was associated with reduced risk for hospitalization for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease

Jardiance (empagliflozin) was associated with a 44 percent reduction in relative risk of hospitalization for heart failure (HHF) compared with commonly used dipeptidyl peptidase-4 inhibitors

November 5, 2018
·
16 min read
FDA

Shoulder Innovations Announces FDA 510(k) Clearance For Shoulder Technology

Shoulder Innovations announced today that they have received FDA clearance for their InSet Humeral Short Stem System.

November 5, 2018
·
2 min read
Aurora Cannabis Increases Cornerstone Investment in Cannabis Retailer Choom with Additional $20,000,000

Aurora secures right to increase ownership to 40% of Choom at $2.75 per common share

November 5, 2018
·
10 min read
Deals

Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) on November 1, 2018

Sage Therapeutics today announced that, on November 1, 2018, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 15,400 shares of its common stock to 12 new employees under Sage’s 2016 Inducement Equity Plan.

November 5, 2018
·
2 min read
Policy

SpringWorks Therapeutics Receives FDA Orphan Drug Designation for MEK Inhibitor (PD-0325901) for the Treatment of Neurofibromatosis Type 1

SpringWorks Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation for PD-0325901, an investigational, oral, small molecule selective inhibitor of MEK1 and MEK2, for the treatment neurofibromatosis type 1.

November 5, 2018
·
6 min read
Trulicity® (dulaglutide) demonstrates superiority in reduction of cardiovascular events for broad range of people with type 2 diabetes

Only 31 percent of REWIND trial participants had established CV disease

November 5, 2018
·
11 min read
Policy

NeoTract Announces Japanese Regulatory Approval for UroLift® System for Treatment of Enlarged Prostate

NeoTract today announced the Company has received Shonin approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for the UroLift® System for the treatment of benign prostatic hyperplasia (BPH).

November 5, 2018
·
4 min read